BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 35133429)

  • 1. Fourth COVID-19 Vaccine Dose Increases Low Antibodies.
    Abbasi J
    JAMA; 2022 Feb; 327(6):517. PubMed ID: 35133429
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2 specific antibody responses after third CoronaVac or BNT162b2 vaccine following two-dose CoronaVac vaccine regimen.
    Keskin AU; Bolukcu S; Ciragil P; Topkaya AE
    J Med Virol; 2022 Jan; 94(1):39-41. PubMed ID: 34536028
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of a Prolonged Booster Interval on Neutralization of Omicron Variant.
    Zhao X; Li D; Ruan W; Chen Z; Zhang R; Zheng A; Qiao S; Zheng X; Zhao Y; Dai L; Han P; Gao GF
    N Engl J Med; 2022 Mar; 386(9):894-896. PubMed ID: 35081296
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine.
    Bradley T; Grundberg E; Selvarangan R; LeMaster C; Fraley E; Banerjee D; Belden B; Louiselle D; Nolte N; Biswell R; Pastinen T; Myers A; Schuster J
    N Engl J Med; 2021 May; 384(20):1959-1961. PubMed ID: 33755375
    [No Abstract]   [Full Text] [Related]  

  • 5. SARS-CoV-2 Antibody Response in Persons with Past Natural Infection.
    Anichini G; Terrosi C; Gandolfo C; Gori Savellini G; Fabrizi S; Miceli GB; Cusi MG
    N Engl J Med; 2021 Jul; 385(1):90-92. PubMed ID: 33852796
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern.
    Yue L; Zhou J; Zhou Y; Yang X; Xie T; Yang M; Zhao H; Zhao Y; Yang T; Li H; Xiang H; Wang J; Lu S; Liu H; Zhao H; Wei X; Zhang Y; Xie Z
    Emerg Microbes Infect; 2021 Dec; 10(1):2125-2127. PubMed ID: 34666622
    [No Abstract]   [Full Text] [Related]  

  • 7. Patients with Solid Tumors Seroconvert after SARS-CoV-2 mRNA Vaccine.
    Cancer Discov; 2021 Sep; 11(9):2122. PubMed ID: 34272229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine.
    Krammer F; Srivastava K; Alshammary H; Amoako AA; Awawda MH; Beach KF; Bermúdez-González MC; Bielak DA; Carreño JM; Chernet RL; Eaker LQ; Ferreri ED; Floda DL; Gleason CR; Hamburger JZ; Jiang K; Kleiner G; Jurczyszak D; Matthews JC; Mendez WA; Nabeel I; Mulder LCF; Raskin AJ; Russo KT; Salimbangon AT; Saksena M; Shin AS; Singh G; Sominsky LA; Stadlbauer D; Wajnberg A; Simon V
    N Engl J Med; 2021 Apr; 384(14):1372-1374. PubMed ID: 33691060
    [No Abstract]   [Full Text] [Related]  

  • 9. A third booster dose may be necessary to mitigate neutralizing antibody fading after inoculation with two doses of an inactivated SARS-CoV-2 vaccine.
    Yue L; Xie T; Yang T; Zhou J; Chen H; Zhu H; Li H; Xiang H; Wang J; Yang H; Zhao H; Wei X; Zhang Y; Xie Z
    J Med Virol; 2022 Jan; 94(1):35-38. PubMed ID: 34516026
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response and Duration of Serum Anti-SARS-CoV-2 Antibodies After Inactivated Vaccination Within 160 Days.
    Xu QY; Xue JH; Xiao Y; Jia ZJ; Wu MJ; Liu YY; Li WL; Liang XM; Yang TC
    Front Immunol; 2021; 12():786554. PubMed ID: 35003104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On reaching herd immunity during the COVID-19 pandemic and further issues.
    Pandolfi S; Chirumbolo S
    J Med Virol; 2022 Jan; 94(1):24-25. PubMed ID: 34491592
    [No Abstract]   [Full Text] [Related]  

  • 13. Should a third booster dose be scheduled after two doses of CoronaVac? A single-center experience.
    Yigit M; Ozkaya-Parlakay A; Cosgun Y; Ince YE; Bulut YE; Senel E
    J Med Virol; 2022 Jan; 94(1):287-290. PubMed ID: 34487373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity after two doses of inactivated virus vaccine in healthcare workers with and without previous COVID-19 infection: Prospective observational study.
    Yalçın TY; Topçu DI; Doğan Ö; Aydın S; Sarı N; Erol Ç; Kuloğlu ZE; Azap ÖK; Can F; Arslan H
    J Med Virol; 2022 Jan; 94(1):279-286. PubMed ID: 34468990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 immunogenicity in individuals infected before and after COVID-19 vaccination: Israel, January-March 2021.
    Abu Jabal K; Ben-Amram H; Beiruti K; Brimat I; Abu Saada A; Bathish Y; Sussan C; Zarka S; Edelstein M
    Epidemiol Infect; 2021 Aug; 149():e239. PubMed ID: 34399868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody Response to mRNA-1273 SARS-CoV-2 Vaccine in Hemodialysis Patients with and without Prior COVID-19.
    Chan L; Fuca N; Zeldis E; Campbell KN; Shaikh A
    Clin J Am Soc Nephrol; 2021 Aug; 16(8):1258-1260. PubMed ID: 34031182
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days.
    Gil-Manso S; Carbonell D; López-Fernández L; Miguens I; Alonso R; Buño I; Muñoz P; Ochando J; Pion M; Correa-Rocha R
    Front Immunol; 2021; 12():726960. PubMed ID: 34671348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.
    Normark J; Vikström L; Gwon YD; Persson IL; Edin A; Björsell T; Dernstedt A; Christ W; Tevell S; Evander M; Klingström J; Ahlm C; Forsell M
    N Engl J Med; 2021 Sep; 385(11):1049-1051. PubMed ID: 34260850
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of Vaccine Type and Prior SARS-CoV-2 Infection With Symptoms and Antibody Measurements Following Vaccination Among Health Care Workers.
    Debes AK; Xiao S; Colantuoni E; Egbert ER; Caturegli P; Gadala A; Milstone AM
    JAMA Intern Med; 2021 Dec; 181(12):1660-1662. PubMed ID: 34398173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 infection long time after full vaccination is related to a lack of neutralizing antibodies.
    Alidjinou EK; Gaillot O; Guigon A; Tinez C; Lazrek M; Bocket L; Engelmann I; Hober D
    Diagn Microbiol Infect Dis; 2022 Jan; 102(1):115565. PubMed ID: 34731684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.